$3.050
-0.030 (-0.97%)收盘时
HAO 资讯
HAO 事件
Haoxi Health Technology Ltd Trading Halted, News Pending
Haoxi Health Technology Ltd trading halted, news pending
Haoxi Health Technology signs AI marketing cooperation framework with Nova Media
Haoxi Health Technology signed a strategic cooperation framework agreement with Nova Media, a technology company with expertise in AI digital humans and generative AI. Under the agreement, Nova Media will develop an AI digital marketing system for HAO that is designed to support content production through AI-enabled tools and standardized workflows. The System will integrate AI digital human technology, automated content generation, and end-to-end workflow automation to support HAO's health-industry marketing operations. The collaboration aims to deliver advanced AI marketing solutions and will focus on developing automating creative content generation and enhancing intelligent decision-making processes to deliver digital marketing solutions to HAO's client base across popular Chinese platforms, including Toutiao, Douyin, WeChat, and Sina Weibo.
Haoxi Health Technology to Sell 10M Shares at $0.40 Each
Haoxi Health Technology announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 10M of the company's Class A ordinary shares at a purchase price of 40c per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for shares, less the exercise price of 33c per share. The aggregate gross proceeds to the company of this offering are expected to be approximately $4M. The transaction is expected to close on or about July 13, subject to the satisfaction of customary closing conditions. Univest Securities is acting as the sole placement agent.
Haoxi Health Technology Ltd Trading Halted, News Pending
Haoxi Health Technology Ltd trading halted, news pending
Haoxi Health Technology Enters $6.5M Securities Agreement with Investors
Haoxi Health Technology announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of approximately $6.5M of the company's securities, including 9M Class A ordinary shares, par value $0.0025 per share and 16,999,998 pre-funded warrants, at a purchase price of 25c per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for shares, less the exercise price of $0.0026 per share. Each pre-funded warrant is exercisable to purchase 10.355 shares. The aggregate gross proceeds to the company of this offering are expected to be approximately $6.5M, before deducting placement agent commissions and other offering expenses. The transaction is expected to close on or about May 12, subject to the satisfaction of customary closing conditions. The company intends to use the net proceeds from this offering for working capital and general corporate purposes. Univest Securities is acting as the sole placement agent.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。